Detalhe da pesquisa
1.
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.
Nat Chem Biol
; 11(7): 511-7, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26030728
2.
The splice is right.
Nat Chem Biol
; 14(12): 1068-1069, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323218
3.
A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
FASEB J
; 27(5): 1820-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23325320
4.
Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.
Nat Chem Biol
; 12(4): 304, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991088
5.
Corrigendum: SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice.
Nat Chem Biol
; 11(9): 741, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26284678
6.
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators.
Nat Commun
; 10(1): 137, 2019 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30635584
7.
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
Cell Rep
; 23(1): 282-296.e4, 2018 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29617667
8.
High-Throughput Functional Analysis Distinguishes Pathogenic, Nonpathogenic, and Compensatory Transcriptional Changes in Neurodegeneration.
Cell Syst
; 7(1): 28-40.e4, 2018 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29936182
9.
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.
Cancer Cell
; 34(2): 225-241.e8, 2018 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30107174
10.
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex.
Nat Commun
; 8: 15522, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28541300
11.
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Nat Med
; 22(6): 672-8, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135740
12.
A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity.
Elife
; 42015 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738228
13.
Drugging unconventional targets: insights from Huntington's disease.
Trends Pharmacol Sci
; 35(2): 53-62, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24388390
14.
Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.
Nat Neurosci
; 16(5): 562-70, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525043
15.
Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Nat Med
; 22(6): 692, 2016 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270779
16.
Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors.
Mol Neurodegener
; 5: 58, 2010 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156064
17.
Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
J Neurochem
; 97(6): 1585-99, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16805770
18.
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.
J Biol Chem
; 279(18): 18614-22, 2004 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-14985362
19.
Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
J Biol Chem
; 278(44): 43628-35, 2003 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-12930822